PD-1 is expressed on T cells, and negatively regulates their antitumor effect, while and PD-L1 is expressed on various human cancers such as lung cancer, breast cancer, and melanoma, as well as on tumor-infiltrating immune cells in the tumor microenvironment [25]. The gene discussed is CD274; the disease is neoplasm.